our company already develops and manufactures antibody therapies. They now wish to explore the use of antibody-drug conjugates. Write a briefing report for the CSO that evaluates the potential benefits and challenges associated with antibody-drug conjugates, giving reference to their: Design Mechanism of action Efficacy Development challenges Manufacturing process and challenges Analytical challenges Keep it brief (2000 words / 5 pages max). Your CSO may have to read it on their way down the corridor to see the CEO. Word count includes references, but be sparing (eg. 3-5 references)